Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.

Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q38393755

about

Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence Intermittent preventive treatment for malaria in children living in areas with seasonal transmission Intermittent preventive antimalarial treatment for children with anaemia Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants.Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends.A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.Community effectiveness of intermittent preventive treatment for infants (IPTi) in rural southern Tanzania Decline in childhood iron deficiency after interruption of malaria transmission in highland Kenya.Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants.Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.Anti-malarial market and policy surveys in sub-Saharan Africa Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania.Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania.High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children Low parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western Kenya Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon.Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea.Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses.A simple method for defining malaria seasonality Influenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants.Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.Socio-economic status is inversely related to bed net use in Gabon.Multi-year optimization of malaria intervention: a mathematical model.The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon.Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review.Brokering the boundary between science and advocacy: the case of intermittent preventive treatment among infants.Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings.

P2860

Q21032450-04810D81-0654-4679-8AD0-594803F2C1B5 Q21032527-45F85F57-497C-4999-BF0B-8BFE3D901BE8 Q24186627-E5F9C5D2-6EB1-4C83-856D-23356BD9CE9D Q28473083-4820AA29-0307-4213-920F-02640B8E6024 Q28473566-4EFF2DB3-46F0-4A97-BDEE-A9070F517336 Q28474404-B9150045-8028-4779-BF82-A6E7D9DB1378 Q28474692-82A1EEDA-5A5A-4F8E-BD0D-C3EF2CF904B5 Q28477679-FD1F91ED-8EFE-448F-B3BA-9B3FEED95DB0 Q33336570-B6804E3E-44F1-404F-9702-D6EF35C13569 Q33343300-1CEE172F-20EF-4F40-914B-FBE37D622CDF Q33351939-23807EAB-CE1A-4094-ACC3-5825E62BFDE8 Q33406496-0EB7D957-74D8-4FD5-9C80-2325EF1D2A5F Q33512921-3EF253F8-E21D-4ACC-8A82-912118B75336 Q33529052-A1C86D61-E677-46A5-8161-BCD1CA6B3AA8 Q33645358-AA46FDBE-316B-40EF-8ACB-0702BBBDDFD0 Q33691573-716E9B5F-2943-461F-A75B-58277A23046F Q33817569-54963F9A-0E34-4B49-81BA-E4B988DFF525 Q34056231-7E0DEF37-865C-404C-A457-D713D0B6CE8D Q34128601-D74972E1-28BE-41DA-9302-6E272166E853 Q34271078-095C56B3-070D-444A-B468-878672EB5C8E Q34405184-2C7362A5-7D61-4AD9-9181-0EBDC94A1B2A Q34407223-EE782377-C256-4320-BBCD-D8C0917C62C6 Q34660009-D5F85E8C-4B63-42C3-B256-9E4A668B56CC Q34960038-7509A32B-8820-4039-A7D1-018D2FAD92C7 Q35038632-888E3AF0-ABE5-4FD1-973A-6A6CB03B2D93 Q35224777-80E3A575-D3A8-4D7C-B2F4-CD484F0AB18A Q35228689-840A18D5-2F01-4C96-A9D3-053DFB5B8E7A Q35549781-DBE44B54-937A-488F-9420-8B11783A2240 Q35573556-460CA13D-9C58-493F-B161-65A9ED244065 Q35573781-D21A9245-0CDA-4187-91D8-63A5C1A80CDB Q35575256-A75C0DF9-4080-4B3E-BD31-DDF41900673F Q35934042-8A8945FD-F4F7-4D08-B745-6EA82893B704 Q36018719-E481F5EB-C43C-42BD-8C56-16B7A111DE02 Q36606694-2B590DE4-34D3-41F1-A3A4-FCD0A72393BF Q36639299-B135CBF5-0B37-4FCF-B24A-AE1E6036E576 Q36958924-AB96D54E-8F44-4EEE-AE3E-74A759A499B6 Q36981978-5066A8A3-2283-4D34-9598-8CDAB12F5C7D Q37107195-5E5F4011-2BE9-409F-97E8-F591D251860D Q37122802-12C765A9-200A-4AC1-A881-C52E793527C6 Q37325652-026E3EE2-7CBA-41DA-B58E-5E5B482E9F59

P2860

Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q38393755

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Intermittent preventive treatm ...... ind, placebo-controlled trial.

@en

type

label

Intermittent preventive treatm ...... ind, placebo-controlled trial.

@en

prefLabel

Intermittent preventive treatm ...... ind, placebo-controlled trial.

@en

P1433

Q38393755-3FE0A220-5CFB-484F-A0A0-047E448AC921

P1476

Q38393755-8DFD4AD7-98F7-483D-9EC7-64255CBAB6F8

P2093

Q38393755-01850FC4-667D-4CF2-A9CC-DF9E1FAF9548

Q38393755-039AFEA6-7C1F-4D07-8D0A-7C0DFFD78083

Q38393755-1286D9A9-898E-45FF-8C60-52BDBFDAED83

Q38393755-141D4E44-E640-4BFE-BB62-1D3DF947A789

Q38393755-185270B8-071D-4035-9DAE-F49C5057499D

Q38393755-2545C370-8ED3-4434-8F9A-057C420DB680

Q38393755-4D39EC2E-C29E-4AC4-84AB-315E43BF5414

Q38393755-5565769D-DD34-496A-BABB-CC8F3FDA4E2E

Q38393755-595C14CF-A5B8-4074-AB8A-B84A731FF23B

Q38393755-5F532875-432A-4E31-AAEB-D26A99E34588

P304

Q38393755-CA2ED1C0-5631-402B-8805-3B5029B8227D

P31

Q38393755-28440AC3-7FB9-49CB-B5AE-74BFFB1793F8

P356

Q38393755-C3F1376F-8615-4656-812D-ACA931061C5F

P407

Q38393755-1538C546-3290-4618-96ED-BFC912486CED

P433

Q38393755-D5949A62-55D9-4606-90DF-B01B60D4366C

P478

Q38393755-5472FAD7-EA9B-40DF-9CB1-21AF0441EB2C

P50

Q38393755-1C06A2D9-2B35-495A-A416-A05D9A37935F

Q38393755-1C66F649-69B8-49D8-A61A-B4AA85CB4668

Q38393755-F7BB7C46-6937-4D00-81F8-D8A5B393FE85

Q38393755-F9FD167B-85C3-485D-9F57-9AD7D0E0C3DE

P577

Q38393755-8FD08F62-C58C-4902-BEED-E1A164D7C91D

P5875

Q38393755-C1291A12-4B62-4E29-8AF2-C3BE4352C59E

P698

Q38393755-EA096DED-71DA-4E8C-9FE8-12B6C3233B91

P921

Q38393755-CCF3A05F-DBDA-49B8-A84D-1AF300AF69A6

Q38393755-D829927E-E813-475D-8484-81CF512CB4F5

Q38393755-F459C5DB-5F76-4A51-AD0D-B22EE9F501EE

P356

P1433

The Journal of Infectious Diseases

P1476

Intermittent preventive treatm ...... ind, placebo-controlled trial.

@en

P2093

Akim A Adegnika

http://www.w3.org/2001/XMLSchema#string

Anna Klopfer

http://www.w3.org/2001/XMLSchema#string

Benjamin Naumann

http://www.w3.org/2001/XMLSchema#string

Carmen L Ospina Salazar

http://www.w3.org/2001/XMLSchema#string

Christian Supan

http://www.w3.org/2001/XMLSchema#string

Davy U Kombila

http://www.w3.org/2001/XMLSchema#string

Georg C Kiessling

http://www.w3.org/2001/XMLSchema#string

Handan Altun

http://www.w3.org/2001/XMLSchema#string

Isabelle von Glasenapp

http://www.w3.org/2001/XMLSchema#string

Jenny Dornemann

http://www.w3.org/2001/XMLSchema#string

P304

1595-1602

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/522160

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

Martin Peter Grobusch

Peter Gottfried Kremsner

P577

2007-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5839314

http://www.w3.org/2001/XMLSchema#string

P698

18008242

http://www.w3.org/2001/XMLSchema#string

P921